Quantinno Capital Management LP Boosts Stake in The Clorox Company (NYSE:CLX)

Quantinno Capital Management LP boosted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 609.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,230 shares of the company's stock after acquiring an additional 13,084 shares during the period. Quantinno Capital Management LP's holdings in Clorox were worth $2,481,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also modified their holdings of the company. Mizuho Securities USA LLC raised its stake in Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock worth $733,095,000 after buying an additional 4,490,421 shares in the last quarter. Nuance Investments LLC lifted its stake in shares of Clorox by 150.6% during the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company's stock worth $218,035,000 after purchasing an additional 960,094 shares during the last quarter. Van ECK Associates Corp boosted its position in Clorox by 2.2% during the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company's stock valued at $237,372,000 after purchasing an additional 31,510 shares in the last quarter. Bank of New York Mellon Corp grew its stake in Clorox by 14.4% in the second quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company's stock valued at $131,200,000 after purchasing an additional 120,716 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in Clorox by 11.9% in the second quarter. Dimensional Fund Advisors LP now owns 802,237 shares of the company's stock worth $109,483,000 after purchasing an additional 85,529 shares in the last quarter. Institutional investors own 78.53% of the company's stock.

Clorox Stock Performance

Shares of NYSE CLX traded down $1.97 during midday trading on Wednesday, reaching $165.69. 597,885 shares of the stock were exchanged, compared to its average volume of 1,229,730. The firm has a market cap of $20.51 billion, a price-to-earnings ratio of 58.44, a PEG ratio of 3.08 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The firm has a 50-day simple moving average of $163.59 and a two-hundred day simple moving average of $150.86. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm's revenue was up 27.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.49 EPS. As a group, analysts anticipate that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 2.95%. Clorox's dividend payout ratio is presently 170.04%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Citigroup raised their target price on shares of Clorox from $165.00 to $170.00 and gave the company a "neutral" rating in a research note on Friday, September 6th. Jefferies Financial Group raised shares of Clorox from a "hold" rating to a "buy" rating and increased their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. BNP Paribas raised shares of Clorox to a "strong sell" rating in a research report on Friday, September 6th. JPMorgan Chase & Co. raised their price target on shares of Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a report on Friday, October 11th. Finally, Barclays upped their target price on Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a research report on Friday, November 1st. Five analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.